Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study
- Resource Type
- Article
- Source
- In
Clinical Oncology January 2024 36(1):39-45 - Subject
- Language
- ISSN
- 0936-6555